Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Emergency aid for overdoses

  • Improving bladder function among people with spinal cord injuries

  • Blinded by non-science: Trivial scientific information increases trust in products

  • Pathological gambling is associated with altered opioid system in the brain

  • Highly connected CEOs more likely to broker mergers and acquisitions that harm firms, study shows

  • Heart rate may predict survival, brain function in comatose cardiac arrest survivors

  • Cold sores increase risk of dementia, research suggests

  • User-friendly electronic 'Eyecane' enhances navigational abilities for blind

  • Design of micro, nanoparticles to improve treatments for Alzheimer's, Parkinson's

  • Sexual preference for masculine men, feminine women is an urban habit

  •